MedPath

Effect of HFCWO Vests on Spirometry Measurements

Not Applicable
Completed
Conditions
Cystic Fibrosis
Bronchiectasis
Interventions
Device: International Biophysics AffloVest
Device: Hill-Rom Monarch
Registration Number
NCT03628456
Lead Sponsor
International Biophysics Corporation
Brief Summary

The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and Tidal Volume is investigated during use of several products and comparing to baseline values

Detailed Description

The study will be broken into one (1) arm:

• AffloVest® \& Monarch™

Within the arm, the order of products will be randomized.

Baseline spirometry (Forced Expiratory Volume (FEV1), Forced Vital Capacity (FVC), Peak Expiratory Flow (PEF), Forced Expiratory Flow (FEF25-75%) and Tidal Volume (TV)) will be taken at the beginning, middle and end of each series of measurements with each subject, without any device on the subject. A product (AffloVest or Monarch) will be placed onto subject and turned ON to the highest frequency and intensity settings. Then the subject will be given a certain period of time to adjust and spirometry measurements will then be repeated, then the product will be removed and the subject will be allowed a recovery period, then the other product will be placed on the subject, turned ON and spirometry measurements will repeated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Healthy subject, ages 18 - 50
Exclusion Criteria
  • Non-ambulatory
  • diagnosed neuromuscular disorder
  • currently using any type of oscillation vest therapy
  • diagnosed co-morbid condition (i.e. lung cancer, other lung disorder or disease)
  • currently enrolled in a medical research study
  • non-English speaking
  • presence of the following active implantable devices: pacemakers, neurostimulators, infusion pumps, circulatory support devices, implantable cardioverter defibrillators (ICD's), cochlear implants
  • presence of head and/or neck injury that has not yet been stabilized
  • presence of active hemorrhage with hemodynamic instability

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AffloVest Monarch ArmInternational Biophysics AffloVestDevices placed on highest intensity / highest frequency
AffloVest Monarch ArmHill-Rom MonarchDevices placed on highest intensity / highest frequency
Primary Outcome Measures
NameTimeMethod
Peak Expiratory Flow (PEF) Assessed in Participants at Baseline and With Both Devices30 minutes

Peak Expiratory Flow (PEF) measures the peak flow during a forced exhalation, measured using standard spirometry techniques

Forced Expiratory Volume (1 Second) Assessed in Participants at Baseline and With Both Devices30 minutes

Forced Expiratory Volume in 1 second (FEV1) measures how much air a person can exhale during a forced breath during the first one (1) second, measured using standard spirometry techniques

Forced Vital Capacity (FVC) Assessed in Participants at Baseline and With Both Devices30 minutes

Forced Vital Capacity (FVC) is the total amount of air exhaled during the FEV test, measured using standard spirometry techniques

Tidal Volume (TV) Assessed in Participants at Baseline and With Both Devices30 minutes

Tidal Volume is the normal volume of air displaced between normal inhalation and exhalation, measured using standard sprirometry techniques

Forced Expiratory Flow (FEF25-75%) Assessed in Participants at Baseline and With Both Devices30 minutes

Forced Expiratory Flow (25-75%) is the average flow from the point at which 25% of the FVC has been exhaled to the point at which 75% of the FVC has been exhaled, measured using standard spirometry techniques

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PDS Research

🇺🇸

Kissimmee, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath